Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Thackray Helen M. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 4 Thackray Helen M. (Director) has filed a Form 4 on ImmunoGen, Inc.
Txns: Granted 472 shares @ $15.87, valued at $7.5k
07/05/2023 4 Thackray Helen M. (Director) has filed a Form 4 on ImmunoGen, Inc.
Txns: Granted 397 shares @ $18.87, valued at $7.5k
06/16/2023 4 Thackray Helen M. (Director) has filed a Form 4 on ImmunoGen, Inc.
Txns: Granted 13,090 restricted stock units @ $0
Granted 19,597 options to buy @ $0
04/05/2023 4 Thackray Helen M. (Chief R&D Officer) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Sold 7,000 shares @ $8.29, valued at $58k
04/04/2023 4 Thackray Helen M. (Director) has filed a Form 4 on ImmunoGen, Inc.
Txns: Granted 1,953 shares @ $3.84, valued at $7.5k
12/21/2022 4 Thackray Helen M. (Chief R&D Officer) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 81,000 shares @ $0
Granted 238,000 options to buy @ $10.63, valued at $2.5M
12/19/2022 4 Thackray Helen M. (Chief R&D Officer) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Sold 3,125 shares @ $10.89, valued at $34k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2022 4 Thackray Helen M. (Chief R&D Officer) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Sold 7,600 shares @ $16.2, valued at $123.1k
12/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/23/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
04/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/24/2020 4 Thackray Helen M. (SVP Clinical Development, CMO) has filed a Form 4 on GLYCOMIMETICS INC
Txns: Granted 120,000 options to buy @ $4.72, valued at $566.4k
09/24/2019 4 Thackray Helen M. (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 40,000 options to buy @ $2.86, valued at $114.4k
09/24/2019 3 Thackray Helen M. (Director) has filed a Form 3 on BIOCRYST PHARMACEUTICALS INC
01/22/2019 4 Thackray Helen M. (SVP Clinical Development, CMO) has filed a Form 4 on GLYCOMIMETICS INC
Txns: Granted 100,000 options to buy @ $10.59, valued at $1.1M
01/12/2018 4 Thackray Helen M. (SVP Clinical Development, CMO) has filed a Form 4 on GLYCOMIMETICS INC
Txns: Granted 75,000 options to buy @ $20.03, valued at $1.5M
12/12/2017 4 Thackray Helen M. (SVP Clinical Development, CMO) has filed a Form 4 on GLYCOMIMETICS INC
Txns: Sold 2,000 shares @ $15.01, valued at $30k
09/18/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/30/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/22/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
10/04/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
07/21/2016 4 Thackray Helen M. (VP Clinical Development, CMO) has filed a Form 4 on GLYCOMIMETICS INC
Txns: Sold 2,000 shares @ $8, valued at $16k
07/06/2016 4 Thackray Helen M. (VP Clinical Development, CMO) has filed a Form 4 on GLYCOMIMETICS INC
Txns: Sold 5,068 shares @ $7.4, valued at $37.5k
Sold 10,136 shares @ $7.01, valued at $71.1k
Sold 6,796 shares @ $6.68, valued at $45.4k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy